App-Quantinova.ai

Refinement of Non-Invasive Diagnostic Criteria to Differentiate Tumor from Bland Portal Vein Thrombosis Before Liver Transplant in Patients With Hepatocellular Carcinoma

C. Sherman - American Transplant Congress (ATC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

Alfa-fetoprotein

Multicenter Study to Develop a Novel Prediction Index for Hepatocellular Carcinoma (HCC) Recurrence After Liver Transplant (LT)

N. Mehta - American Transplant Congress (ATC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

Alfa-fetoprotein

Alpha-Fetoprotein as a Modifier of Anatomic Criteria for Transplantation of HCC Patients

A. Daoud - American Transplant Congress (ATC) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

Alfa-fetoprotein

Association Between Polymorphisms of PPM1E Gene and Tumor Size of Hepatocellular Carcinoma Patients

M.-S. Park - American Transplant Congress (ATC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

Fibrinogen (IV)

Associations Between Sirolimus Use and Outcomes After Liver Transplant for Hepatocellular Carcinoma

E. Yanik - American Transplant Congress (ATC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

Alfa-fetoprotein

Listing for Liver Transplantation of Patients With Hepatocellular Carcinoma Using the Extended Toronto Criteria; an Intention-to-Treat Analysis

G. Sapisochin - American Transplant Congress (ATC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

Recurrence of Hepatocellular Carcinoma After Transarterial Chemoembolization (TACE) Alone and TACE in Combination With Other Treatment Modalities

J. Balogh - American Transplant Congress (ATC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

Risk of Post Liver Transplant (LT) Hepatocellular Carcinoma (HCC) Recurrence Is 2-Fold Higher in Women Compared to Men With AFP Levels at LT Between 101-500

M. Sarkar - American Transplant Congress (ATC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

Fibrinogen (IV)

A mass spectrometry based serum test for the detection of hepatocellular carcinoma (HCC) in high risk patients

Devalingam Mahalingam - American Association for Cancer Research (AACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

Integrated genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups

Dolores H. Lopez-Terrada - American Association for Cancer Research (AACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

DNA copy number variation and driver mutation patterns of follicular thyroid tumors

Hyun-seok Kim - American Association for Cancer Research (AACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

A gene signature defines chromosomal instability (CIN) and poor survival in liver cancer patients

Sofia Weiler - American Association for Cancer Research (AACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

Changes in plasma circulating DNA composition during focal ablative therapy for liver cancer

Maarit I. Tiirikainen - American Association for Cancer Research (AACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

A short ASPM splicing variant but not the full length variant as a molecular target in hepatocellular carcinoma

Hung-Wei Pan - American Association for Cancer Research (AACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Primary microcephaly

N/A

Hallmark of immune responses to multiple tumor-associated antigens (TAAs) in immunodiagnosis of hepatocellular carcinoma (HCC) and other solid tumors

Liping Dai - American Association for Cancer Research (AACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

Hepatic microRNA as biomarker for detection of hepatocellular carcinoma in high-risk chronic Hepatitis B patients

Amit Ghosh - American Association for Cancer Research (AACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Liver cancer

Alfa-fetoprotein

Secretory ANXA3 endows liver cancer cells with tumorigenic and self-renewal abilities and promotes HCC development

Man Tong - American Association for Cancer Research (AACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

Alfa-fetoprotein

BP1 protein, a transcription factor, is secreted by breast cancer cells

Jinguen Rheey - American Association for Cancer Research (AACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

Alfa-fetoprotein

High MET and CA9 expressions define a subgroup of hepatocellular carcinoma (HCC) patients with poor prognosis candidates for MET inhibition strategy

Annemilai Tijeras-Raballand - American Association for Cancer Research (AACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

Cluster of Acute Flaccid Paralysis and Cranial Nerve Dysfunction in Children Temporally Associated with an Enterovirus D68 Outbreak in Colorado

Teri Schreiner - American Academy of Neurology (AAN) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

Filters

486 Abstracts